Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
2
×
biotech
2
×
europe top stories
2
×
fda
life sciences
national
national blog main
national top stories
new york top stories
novartis
2
×
san francisco top stories
accent therapeutics
aducanumab
alzheimer's disease
amblyotech
asklepios biopharmaceutical
billy dunn
bioeurope
biomarin pharmaceutical
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
brainvectis
c. greg guyer
cancer
cara therapeutics
clinical trials
deerfield management
detroit blog main
detroit top stories
drug development
drug discovery
drug prices
drug pricing
esperion
europe blog main
evrysdi
financing
gene therapy
What
fda
new
2
×
activity
approvals
approved
atrophy
bio
biogen
clamped
covid
daily
delays
developing
drug
economic
evrysdi
fast
friday
green
home
including
intended
ipo
isn’t
lights
liquid
lot
medicine
medicines
muscular
oral
oric’s
patients
risdiplam
roche
roundup
showing
spinal
spread
testing
Language
unset
Current search:
biogen
×
new
×
biotech
×
novartis
×
" europe top stories "
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More